NightHawk Biosciences (NHWK) has released an update to notify the public and investors about the unregistered sales of equity securities.
The information from Item 1.01 is fully included in Item 3.02 of the Current Report. The Note and potential common stock issued under it are being offered in a transaction exempt from registration, based on Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D.
For further insights into NHWK stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
